Can Wegovy Cause Skin Rash or Other Skin Reactions?

Injection-site reactions — redness, itching, bruising or small lumps at the injection point — are the most frequently reported skin side effect of semaglutide.
A small proportion of people develop a more generalised rash or hives (urticaria); rarely, this signals an allergic response that needs urgent assessment.
Rotating injection sites (abdomen, thigh, upper arm) each week reduces the risk of localised skin irritation building up in one spot.
Any rash accompanied by difficulty breathing, facial swelling or a rapidly spreading reaction should be treated as a medical emergency.

Wegovy can cause skin reactions in some people. Injection-site redness, itching and localised swelling are the most commonly reported ones, and a small number of people do experience a more widespread rash while taking semaglutide. Most reactions are mild and short-lived, though some warrant prompt medical attention. As a prescription-only medicine, Wegovy is assessed individually by a clinician before it is prescribed, and any skin changes during treatment should be discussed with your prescribing team rather than managed alone.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and prescribers say about semaglutide skin reactions

Step 1: Recognise what type of skin reaction you are dealing with

Not all rashes connected to Wegovy are the same thing, and knowing which category yours fits into shapes how urgently you need to act. The NHS semaglutide medicines page groups skin effects into three broad presentations.

The most common is a localised injection-site reaction: a patch of redness, warmth, mild swelling or itching directly where the pen was used. This often settles within a day or two and is partly a mechanical response to the needle and fluid, not purely a drug effect. Rotating where you inject each week is the single most effective way to keep these reactions from becoming a persistent problem.

The second presentation is a more widespread skin rash or urticaria (raised, itchy welts that can appear anywhere on the body). This is less common but is listed in the Wegovy prescribing information as a known side effect of semaglutide. It can appear shortly after starting treatment or after a dose increase, when the drug level in your system is climbing.

The third, rarest and most serious presentation is an allergic or anaphylactic reaction: a rapidly spreading rash or hives alongside symptoms such as swelling of the face, lips or throat, shortness of breath, or a sudden drop in blood pressure. This requires emergency medical help immediately, call 999. It is uncommon, but the prescribing team at a service like ours will always screen for known drug allergies before treatment begins, precisely to reduce this risk.

Step 2: Understand why semaglutide might affect the skin at all

Semaglutide is a GLP-1 receptor agonist, meaning it mimics a gut hormone involved in appetite regulation and blood-sugar balance. It is not a medicine that acts directly on skin tissue, which is why widespread rashes are relatively uncommon compared with, say, antibiotics or NSAIDs. When they do occur, the most plausible mechanisms are immune-mediated sensitivity to the molecule itself, the excipients in the formulation, or a delayed hypersensitivity response at the injection site that has been scratched or rubbed. Our page on whether Wegovy can cause a rash covers the full picture of how and why these reactions happen.

Dry or irritated skin around injection sites is also occasionally reported. If you have noticed that texture change alongside any itching, our page on whether Wegovy causes dry skin covers what is known about that specific concern.

Changes in body composition during weight loss can sometimes alter skin appearance too, loose or less taut skin as fat volume reduces is a separate matter from a drug-induced rash. For anyone wondering about that distinction, the question of whether Wegovy causes loose skin is addressed separately.

The clinical trial data for semaglutide (including the STEP 1 study published in the New England Journal of Medicine) recorded side effects systematically across nearly 2,000 participants. Gastrointestinal effects dominated; skin reactions were present but not among the leading reported events, which puts their overall frequency in context.

Step 3: Know when to get medical help and what to report

Mild localised redness after injecting rarely needs more than a cool compress and a different injection site next time. A more generalised rash that is spreading, intensely itchy or not improving within a few days should be discussed with your prescriber or GP. Do not simply stop treatment without guidance, because abrupt discontinuation has its own implications for blood sugar and appetite regulation.

If any rash appears alongside swelling around the face or mouth, a tight or swollen throat, wheezing, or a sudden feeling of faintness, seek emergency help straight away. These are warning signs of a serious allergic reaction, regardless of how mild the rash itself looks.

The MHRA's Yellow Card scheme exists for exactly this kind of situation. Reporting a suspected side effect (even one you are unsure about) contributes to the ongoing safety monitoring of semaglutide and helps regulators spot patterns that clinical trials may not have captured. You can submit a report at yellowcard.mhra.gov.uk.

If you are treated through a regulated service, aftercare support means you have a direct route to a prescriber when something unexpected happens. At nume, that support runs seven days a week, so a skin change on a Sunday is not something you have to sit on until Monday.

Questions about how semaglutide compares to tirzepatide on side-effect profiles, or what semaglutide involves more broadly, are worth raising during a consultation. Our Wegovy treatment overview sets out what the medicine involves from a clinical standpoint, and if cost is a consideration alongside safety, our Wegovy pricing page explains what is included in a private prescription service honestly. If you are ready to have your questions answered by a real prescriber, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions